# AKT and ERK dual inhibitors: The way forward?

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/akt-and-erk-dual-inhibitors-the-way-forward/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Zhe Cao,Qianjin Liao,Min Su,Kai Huang,Junfei Jin,Deliang Cao |
| Citations | 230 |
| DOI | 10.1016/j.canlet.2019.05.025 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.sciencedirect.com/science/article/pii/S0304383519303209/pdf |
| OpenAlex ID | https://openalex.org/W2946572822 |
| PMID | 31128213 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Junfei Jin](https://scholariq.org/researchers/junfei-jin/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.